Idarucizumab
Brand: Praxbind
No boxed warning on the current FDA label.
- Caution
- Thrombotic risk returns once dabigatran is reversed; 5 g dose given as two consecutive 2.5 g vials.
- Storage
- Refrigerate vials (36 to 46 F); do not freeze, protect from light; once at room temperature use within 48 hours.
Common side effects
- Headache
- Low potassium
- Constipation
- Fever
Key interactions
- Specific to dabigatran; does not reverse apixaban or rivaroxaban
Counseling points
- Given intravenously in an emergency setting
- Clotting risk returns once dabigatran is reversed
We ask 5 questions about Idarucizumab.Practice Idarucizumab →Test yourself on medications like Idarucizumab.Practice Medications →
High-yield study aid for exam prep, not a substitute for the package insert or a pharmacist’s dispensing reference.